No difference in primary diagnosis for anti-TNF agent use was reported with RA (P = 0.119), psoriatic arthritis (P = 0.167), ankylosing spondylitis (P = 0.474), and other conditions (P = 0.157) between the three anti-TNF agents. Here, TNF is linked to rheumatoid arthritis.